EP01.02-007 It’s Not How You Start, It’s How You Finish: Patient Motivators to Follow Low-Dose Screening Recommendations

Abstract

Low-Dose CT (LDCT) for lung cancer screening (LCS) is recommended for ages 50-80 with 20 pack-years smoking history that currently smoke or have quit within 15 years. Although LCS decreases lung cancer mortality 20-25%, recent US screening rates are only 6.5%. Furthermore, adherence to follow-up is suboptimal outside of studies due to provider, patient, and system barriers. Our goal was to explore patients’ motivating factors and deterrents to LDCT follow-up in an underserved population.